81 results
8-K
EX-99.1
RGEN
Repligen Corp.
1 May 24
Repligen Reports First Quarter 2024 Financial Results
7:44am
, both sequentially and year-over-year. Our latest acquisition – Metenova – continued to achieve both revenue and orders targets. We also saw continued
8-K
EX-99.2
ce9ujw
16 Sep 21
Proposed acquisition strengthens Repligen’s Proteins business
7:53am
DEFR14A
f2by9 a1a9767lj
5 May 21
Revised proxy
4:16pm